Published in Arteriosclerosis on February 23, 1989
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ (1994) 11.85
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ (1990) 6.70
Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ (1992) 6.33
Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ (1993) 6.23
Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79
Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr (2010) 4.85
Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med (2010) 4.79
Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ (2001) 3.29
Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ (1996) 3.27
Dietary reduction of serum cholesterol concentration: time to think again. BMJ (1991) 3.10
Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr (2010) 2.46
Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ (2016) 2.17
Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation (2005) 2.12
Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr (2004) 1.98
Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids (2010) 1.75
Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst Rev (2011) 1.57
Effect of reducing total fat intake on body weight: systematic review and meta-analysis of randomised controlled trials and cohort studies. BMJ (2012) 1.55
The impact of health care advice given in primary care on cardiovascular risk. CELL Study Group. BMJ (1995) 1.45
A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur J Nutr (2009) 1.38
Influence of dairy product and milk fat consumption on cardiovascular disease risk: a review of the evidence. Adv Nutr (2012) 1.34
Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials. Am J Public Health (1997) 1.16
All PUFAs are not created equal: absence of CHD benefit specific to linoleic acid in randomized controlled trials and prospective observational cohorts. World Rev Nutr Diet (2011) 0.90
The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease. Prog Cardiovasc Dis (2015) 0.87
The evidence for α-linolenic acid and cardiovascular disease benefits: Comparisons with eicosapentaenoic acid and docosahexaenoic acid. Adv Nutr (2014) 0.83
Serum lipids and mood in working men and women in Sweden. J Epidemiol Community Health (1994) 0.81
Associations of plasma phospholipid omega-6 and omega-3 polyunsaturated Fatty Acid levels and MRI measures of cardiovascular structure and function: the multiethnic study of atherosclerosis. J Nutr Metab (2011) 0.80
Sleep duration in elderly obese patients correlated negatively with intake fatty. Lipids Health Dis (2012) 0.80
Don't disregard the essential distinction between PUFA species. Br J Nutr (2011) 0.79
The cardiac and haemostatic effects of dietary hempseed. Nutr Metab (Lond) (2010) 0.78
Impact of omega-6 fatty acids on cardiovascular outcomes: A review. J Preventive Cardiol (2013) 0.77
Food science and food ingredients: the need for reliable scientific approaches and correct communication, Florence, 24 March 2015. Int J Food Sci Nutr (2015) 0.76
Saturated Fatty Acids and Cardiovascular Disease: Replacements for Saturated Fat to Reduce Cardiovascular Risk. Healthcare (Basel) (2017) 0.76
Lipids: A hole in the diet-heart hypothesis? Nat Rev Cardiol (2016) 0.75
Hyperlipidemia: Part 1. Evaluation and dietary management. West J Med (2001) 0.75
Meta-analysis by the Program on the Surgical Control of the Hyperlipidemias (POSCH) investigators. Ann Surg (1998) 0.75
Ischaemic heart disease and cholesterol. Optimism about drug treatment is unjustified. BMJ (1994) 0.75
All cholesterol-lowering interventions are expected to reduce stroke: Confirmatory data from IMPROVE-IT. Data Brief (2016) 0.75
Evidence from randomised controlled trials does not support current dietary fat guidelines: a systematic review and meta-analysis. Open Heart (2016) 0.75
Dietary fats: a new look at old data challenges established wisdom. BMJ (2016) 0.75
n-6 Fatty acids and risk for CHD: consider all the evidence. Br J Nutr (2011) 0.75
[Dietary treatment of mild to moderate hypercholesterolemia. Effectiveness of different interventions]. Can Fam Physician (1996) 0.75
Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes (1970) 6.68
The pentose cycle, triose phosphate isomerization, and lipogenesis in rat adipose tissue. J Biol Chem (1966) 2.72
A comparison between carboxyhemoglobin and serum thiocyanate determinations as indicators of cigarette smoking. Am J Public Health (1980) 2.62
Effects of catecholamines on the neuromuscular junction in the rat diaphragm. J Physiol (1970) 2.04
Release of calcium ions linked to the activation of potassium conductance in a caffeine-treated sympathetic neurone. J Physiol (1980) 1.90
Synaptic events in sympathetic ganglia. Prog Neurobiol (1978) 1.88
Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.79
Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique. Clin Chem (1976) 1.71
Characteristics of fast excitatory postsynaptic current in bullfrog sympathetic ganglion cells. Effects of membrane potential, temperature and Ca ions. Pflugers Arch (1979) 1.70
Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin Chem (1978) 1.63
Effect of prostigmine on the time course of the end-plate potential in the rat diaphragm. J Physiol (1971) 1.54
Effect of histrionicotoxin on the ionic conductance modulator of the cholinergic receptor: a quantitative analysis of the end-plate current. J Pharmacol Exp Ther (1974) 1.51
Rhythmic hyperpolarizations and depolarization of sympathetic ganglion cells induced by caffeine. J Neurophysiol (1976) 1.50
Effect of thermal stress on Frank-Starling relations in humans. J Physiol (2009) 1.46
Effects of heat and cold stress on central vascular pressure relationships during orthostasis in humans. J Physiol (2007) 1.45
Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem (1991) 1.43
Analysis of the slow excitatory postsynaptic potential in bullfrog sympathetic ganglion cells. Jpn J Physiol (1976) 1.43
A study of the irreversible cholinesterase inhibitor, diisopropylfluorophosphate, on time course of end-plate currents in frog sartorius muscle. J Pharmacol Exp Ther (1974) 1.43
Origin of calcium ions involved in the generation of a slow afterhyperpolarization in bullfrog sympathetic neurones. Pflugers Arch (1983) 1.36
Characteristics of Ca2+ release induced by Ca2+ influx in cultured bullfrog sympathetic neurones. J Physiol (1993) 1.35
Simulation of intracellular Ca2+ oscillation in a sympathetic neurone. J Theor Biol (1981) 1.30
Sustained potentiation of transmitter release by adrenaline and dibutyryl cyclic AMP in sympathetic ganglia. Nature (1981) 1.27
(+)-Tubocurarine blocks the Ca2+-dependent K+-channel of the bullfrog sympathetic ganglion cell. Brain Res (1984) 1.27
Cholesterol, triglyceride, and phospholipid content of intima, media, and atherosclerotic fatty streak in human thoracic aorta. J Clin Invest (1966) 1.19
Diisopropylfluorophosphate: suppression of ionic conductance of the cholinergic receptor. Science (1973) 1.17
Estimations of pathway contributions to glucose metabolism and the transaldolase reactions. J Biol Chem (1966) 1.16
Comparison of a computerized and a manual method of food coding for nutrient intake studies. J Am Diet Assoc (1988) 1.14
Inhibition of transmitter release in bullfrog sympathetic ganglia induced by gamma-aminobutyric acid. J Physiol (1980) 1.14
Noradrenaline action on nerve terminal in the rat diaphragm. J Physiol (1971) 1.13
A Ca2+-induced Ca2+ release mechanism involved in asynchronous exocytosis at frog motor nerve terminals. J Gen Physiol (1998) 1.12
The effects of exercise and weight loss on plasma lipids in young obese men. Metabolism (1985) 1.12
Functional triads consisting of ryanodine receptors, Ca(2+) channels, and Ca(2+)-activated K(+) channels in bullfrog sympathetic neurons. Plastic modulation of action potential. J Gen Physiol (2000) 1.12
Method issues in dietary data analyses in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr (1997) 1.12
Calcium localization in the sympathetic ganglion of the bullfrog and effects of caffeine. Brain Res (1980) 1.10
Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene (1998) 1.09
Preventing heart disease: is treating the high risk sufficient? J Clin Epidemiol (1988) 1.08
Cyclic ADP-ribose modulates Ca2+ release channels for activation by physiological Ca2+ entry in bullfrog sympathetic neurons. Neuron (1994) 1.08
Ionic mechanism of the slow excitatory postsynaptic potential in bullfrog sympathetic ganglion cells. Brain Res (1974) 1.07
Functional coupling of Ca(2+) channels to ryanodine receptors at presynaptic terminals. Amplification of exocytosis and plasticity. J Gen Physiol (2000) 1.06
Basal Ca2+ and the oscillation of Ca2+ in caffeine-treated bullfrog sympathetic neurones. J Physiol (1992) 1.05
Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model. Cancer Res (2001) 1.05
Differential effects of apamin on Ca2+-dependent K+ currents in bullfrog sympathetic ganglion cells. Neurosci Lett (1986) 1.02
Effects of exercise intensity on flow mediated dilation in healthy humans. Int J Sports Med (2012) 1.01
Relationship between fatty-acid composition of platelets and platelet aggregation in rat and man. Relation to thrombosis. Circ Res (1970) 1.01
The muscarinic effects of acetylcholine on the action potential of bullfrog sympathetic ganglion cells. Jpn J Physiol (1976) 1.00
Lipid concentrations in serum and EDTA-treated plasma from fasting and nonfasting normal persons, with particular regard to high-density lipoprotein cholesterol. Clin Chem (1983) 0.99
Sustained rise in ACh sensitivity of a sympathetic ganglion cell induced by postsynaptic electrical activities. Nature (1983) 0.97
Muscarinic regulation of two ionic currents in the bullfrog sympathetic neurone. Pflugers Arch (1988) 0.96
The Ca2+-sensitive K+-currents underlying the slow afterhyperpolarization of bullfrog sympathetic neurones. Pflugers Arch (1987) 0.95
Fatty acid composition of human adipose tissue related to age, sex, and race. Am J Clin Nutr (1967) 0.95
A patch-clamp study on the muscarine-sensitive potassium channel in bullfrog sympathetic ganglion cells. J Physiol (1992) 0.95
Model studies of blood-glucose regulation. Bull Math Biophys (1965) 0.95
Ca(2+)-induced Ca2+ release and its activation in response to a single action potential in rabbit otic ganglion cells. J Physiol (1995) 0.95
Long-term potentiation of transmitter release induced by repetitive presynaptic activities in bull-frog sympathetic ganglia. J Physiol (1985) 0.95
Intracellular calcium dynamics in response to action potentials in bullfrog sympathetic ganglion cells. J Physiol (1992) 0.94
Prevalence of anaemia and iron deficiency in urban Haïtian children two to five years of age. J Trop Pediatr (1998) 0.93
An enzymatic approach to lipoprotein quantification. Am J Clin Pathol (1980) 0.93
Studies of diabetic instability. II. Tests of insulinogenic reserve with infusions of arginine, glucagon, epinephrine, and saline. Metabolism (1971) 0.92
The action of phenol on neuromuscular transmission in the red muscle of fish. Jpn J Physiol (1969) 0.91
Treatment of type III hyperlipoproteinemia with four different treatment regimens. Atherosclerosis (1984) 0.90
Regulation of two ion channels by a common muscarinic receptor-transduction system in a vertebrate neuron. Neurosci Lett (1987) 0.90
Blood lipids and lipoproteins in a Minnesota urban population. J Chronic Dis (1980) 0.90
Design of dietary experiments for preventing myocardial infarction. J Am Diet Assoc (1968) 0.90
Ca2+ dynamics at the frog motor nerve terminal. Pflugers Arch (2000) 0.89
Presynaptic inhibition by gamma-aminobutyric acid in bullfrog sympathetic ganglion cells. Brain Res (1978) 0.89
Effects of Na+ gradient on the intracellular Ca2+ oscillation in the sympathetic ganglion cell: Na-Ca exchange in the neurone cell soma? Brain Res (1984) 0.89
Ca(2+)-dependent Ca(2+) clearance via mitochondrial uptake and plasmalemmal extrusion in frog motor nerve terminals. J Neurophysiol (2002) 0.89
Measurement of intracellular Ca2+ in the bullfrog sympathetic ganglion cells using fura-2 fluorescence. Brain Res (1988) 0.89
Effects of elabutoxins on neuromuscular transmission in frog skeletal muscles. J Pharmacol Exp Ther (1978) 0.88
Postsynaptic potentiation of the slow muscarinic excitatory response by tetraethylammonium chloride in the bullfrog sympathetic ganglion cells. Brain Res (1977) 0.88
Inhibitory action of Ca2+ on spontaneous transmitter release at motor nerve terminals in a high K+ solution. Pflugers Arch (1980) 0.88
A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). The MRFIT Research Group. Control Clin Trials (1991) 0.88
Long-term potentiation induced by a sustained rise in the intraterminal Ca2+ in bull-frog sympathetic ganglia. J Physiol (1991) 0.87
Oscillation of [Ca2+]i-linked K+ conductance in bullfrog sympathetic ganglion cell is sensitive to intracellular anions. Nature (1980) 0.87
Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugation. Clin Chem (1976) 0.87
HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model. Diabetologia (2002) 0.86
Independence of presynaptic bimodal actions of adrenaline in sympathetic ganglia. Brain Res (1983) 0.86
Dietary intake in the Multiple Risk Factor Intervention Trial (MRFIT): nutrient and food group changes over 6 years. J Am Diet Assoc (1986) 0.86
Role of ion conductance changes and of the sodium-pump in adrenaline-induced hyperpolarization of rat diaphragm muscle fibres. Br J Pharmacol (1987) 0.85
NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells. Br J Cancer (2001) 0.85
Continuous blood glucose analysis in ambulatory fed subjects. I. General methodology. Mayo Clin Proc (1968) 0.85
Pathways of acetoacetate's formation in liver and kidney. J Biol Chem (1982) 0.84
Angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Cell Mol Life Sci (2007) 0.84
Novel action of a piperazine derivative on the end-plate of the frog. Jpn J Physiol (1976) 0.84
Effects of noradrenaline on miniature end-plate potentials and on end-plate potential. J Theor Biol (1972) 0.84
Modeling blood glucose dynamics. Behav Sci (1970) 0.84
Long-term potentiation of transmitter release induced by adrenaline in bull-frog sympathetic ganglia. J Physiol (1986) 0.83
Effects of K+-channel blockers on transmitter release in bullfrog sympathetic ganglia. J Pharmacol Exp Ther (1985) 0.82
Growth hormone and glucose interrelationships in diabetes: studies of inadvertent hypoglycemic episodes during continuous blood glucose analysis. J Clin Endocrinol Metab (1971) 0.82
The International Partnership for Health Informatics Education: lessons learned from six years of experience. Methods Inf Med (2005) 0.82
Feasibility study of a statewide pathology-based cancer surveillance system in Minnesota. I. Information characteristics. J Med Syst (1987) 0.82
The mechanism of the inhibitory action of adrenaline on transmitter release in bullfrog sympathetic ganglia: independence of cyclic AMP and calcium ions. Br J Pharmacol (1985) 0.82
Racial contrasts in hemoglobin levels and dietary patterns related to hematopoiesis in children: the Bogalusa Heart Study. Am J Public Health (1987) 0.81
Measurement of blood cholesterol with the Reflotron analyzer evaluated. Clin Chem (1988) 0.81
Estimation of the glucuronic acid pathway contribution to glucose metabolism in adipose tissue and the effect of growth hormone. J Biol Chem (1966) 0.80
Effects of erabutoxins on the cholinergic receptors of bullfrog sympathetic ganglion cells. Brain Res (1980) 0.80
Modes of propagation of Ca(2+)-induced Ca2+ release in bullfrog sympathetic ganglion cells. Cell Calcium (2000) 0.80
The International Partnership in Health Informatics Education. Stud Health Technol Inform (2004) 0.80
The mode of action of fluoride ions on neuromuscular transmission in frogs. Neuropharmacology (1978) 0.80